Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nektar Therapeutics (NQ: NKTR ) 1.380 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 1.380 Bid (Size) 0.5520 (2) Ask (Size) 1.700 (2) Prev. Close 1.380 Today's Range 1.380 - 1.380 52wk Range 0.4127 - 1.928 Shares Outstanding 183,801,441 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News NKTR Stock Earnings: Nektar Therapeutics Meets EPS, Beats Revenue for Q1 2024 May 09, 2024 NKTR stock results show that Nektar Therapeutics met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's After-Market Session May 07, 2024 Via Benzinga Performance YTD +132.01% +132.01% 1 Month +11.29% +11.29% 3 Month -5.48% -5.48% 6 Month +146.43% +146.43% 1 Year +157.56% +157.56% More News Read More 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 30, 2024 Via Benzinga Sweet Nektar? April 22, 2024 Via Talk Markets 12 Health Care Stocks Moving In Thursday's Intraday Session April 11, 2024 Via Benzinga Nektar Therapeutics Earnings Preview March 01, 2024 Via Benzinga Recap: Nektar Therapeutics Q3 Earnings November 07, 2023 Via Benzinga A Preview Of Nektar Therapeutics's Earnings November 06, 2023 Via Benzinga Expert Ratings for Nektar Therapeutics May 10, 2023 Via Benzinga Biotech's Lawsuit With Eli Lilly Might Catalyze Stock March 29, 2024 Via Talk Markets Topics Lawsuit Exposures Financial Legal Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session March 04, 2024 Via Benzinga Nektar Therapeutics: Q1 Earnings Insights May 09, 2023 Via Benzinga Earnings Scheduled For March 4, 2024 March 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session January 12, 2024 Via Benzinga The One-Minute Market Report - Saturday, Aug. 12 August 12, 2023 Via Talk Markets Topics ETFs 12 Health Care Stocks Moving In Tuesday's After-Market Session August 08, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session August 07, 2023 Via Benzinga Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session August 07, 2023 Via Benzinga Why Is Nektar Therapeutics Stock Surging Today? August 07, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session August 07, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023 May 10, 2023 Via Benzinga Tempur Sealy International To Rally Around 32%? Here Are 10 Other Analyst Forecasts For Wednesday May 10, 2023 Via Benzinga Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions April 18, 2023 Via Benzinga 7 Sorry Pharma Stocks to Sell in April Before It’s Too Late April 16, 2023 Via InvestorPlace Analysts At H.C. Wainwright & Co. Set 12-Month Target Of $15 Per Share For ENLV Thanks To High Profile Collaboration Agreement, Multiple Ongoing Clinical Trials April 13, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
